Partner Headlines - BCRX

  1. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  2. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  3. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  4. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  5. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  6. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga
  7. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 ...

    Benzinga
  10. Making Money With Charles Payne: 10/0614

    FoxBusiness
  11. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD
  12. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  13. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement ...

    Benzinga
  14. Markets Open Higher; Hewlett-Packard Plans To Split Into Two ...

    Benzinga
  15. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  16. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  17. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  18. Morning Market Movers

    Benzinga
  19. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  20. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat ...

    Benzinga
  21. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga
  22. BioCryst Receives Additional NIAID Funding For Manufacture and ...

    Benzinga
  23. Momentum Stocks Showing Weakness

    Benzinga
  24. BioCryst Announces RAPIVAB Trial Results For The Treatment Of ...

    Benzinga
  25. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety ...

    Benzinga
  26. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  27. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  28. Biotechs That Might Benefit From Ebola

    Benzinga
  29. Benzinga's Top #PreMarket Gainers

    Benzinga
  30. Stocks Hitting 52-Week Highs

    Benzinga
  31. Benzinga's Top Initiations

    Benzinga
  32. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  33. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  34. Ebola Stocks Continue Higher

    Benzinga
  35. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  36. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  37. Benzinga's Top Initiations

    Benzinga
  38. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  39. Benzinga's Top #PreMarket Gainers

    Benzinga
  40. Benzinga's Top Downgrades

    Benzinga
  41. Benzinga's Top Initiations

    Benzinga
  42. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  43. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  44. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  45. Benzinga's Top #PreMarket Gainers

    Benzinga
  46. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  47. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  48. Benzinga's Top Pre-Market Gainers

    Benzinga
  49. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  50. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  51. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  52. Benzinga's Top Pre-Market Gainers

    Benzinga
  53. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  54. Benzinga's Top Pre-Market Gainers

    Benzinga
  55. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  56. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  57. Benzinga's Top Pre-Market Losers

    Benzinga
  58. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  59. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  60. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  61. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  62. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  63. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  64. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
  65. Benzinga's M&A Chatter for Thursday October 18, 2012

    Benzinga
  66. BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

    Benzinga
  67. BioCryst Pharmaceuticals, Presidio Pharmaceuticals to Merge

    Benzinga
  68. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  69. A Peek Into The Market Before The Trading Starts

    Benzinga
  70. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  71. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  72. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  73. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga
  74. Benzinga's Microcap Movers for Thursday January 12, 2012

    Benzinga
  75. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga
  76. UPDATE: Bank of America Meets with BioCryst Pharma Management ...

    Benzinga
  77. Bank of America Comments on BCRX Phase-3 Data

    Benzinga
  78. BoardCentral StockTalk - weekly update: AAPL, F, MSFT, KERX, ...

    BoardCentral
Trading Center